INTRODUCTION
Stearoyl-CoA desaturase (Scd, EC 1.14.99.5) is an iron-containing enzyme that catalyses the oxidation of palmitoyl-CoA and stearoyl-CoA at the ∆* position to form the mono-unsaturated fatty acyl-CoA esters, palmitoleoyl-CoA and oleoylCoA, respectively [1] . The introduction of the cis double bond is catalysed by a set of microsomal electron-transport proteins composed sequentially of NADH-cytochrome b5 reductase, cytochrome b5 and the terminal Scd. Electrons flow from NADPH through NADH-cytochrome b5 reductase to cytochrome b5 with cytochrome b5 as the direct electron donor to the desaturase [2] . The rate-limiting step in this reaction is at the desaturase, the complex regulation of which includes diet [3] [4] [5] [6] , hormones [7] [8] [9] [10] [11] [12] , temperature [13, 14] , metals [2, 15] , peroxisomal proliferators [16, 17] and developmental processes [18] .
Oleic acid, the principal product of Scd, is the major unsaturated fatty acid in lipid stores of human adipose tissue [19] and in the phospholipids of the red-blood-cell membrane [20] . The ratio of stearic acid to oleic acid has been implicated in the regulation of cell growth and differentiation through effects on cell-membrane fluidity [21] and signal transduction [22] . Increasing the ratio of stearic to oleic acids induces apoptosis in rat ventricular myocytes [23] , whereas enrichment of oleate in lowdensity-lipoprotein particles confers resistance to oxidation [24] . Similarly, oleic acid is an endogenous anti-oxidant present in intestinal mucosa [25] . Furthermore, altered levels of Scd activity and\or mRNA levels correlate with senescence [26] and neoplasia [27, 28] .
The first mammalian Scd cDNA was isolated from rat liver and consists of a 4.9 kb sequence with a 1.0 kb open reading Abbreviations used : RACE, rapid amplification of cDNA ends ; SCD, Scd, stearoyl-CoA desaturase gene and mRNA/cDNA/protein, respectively ; RFLP, restriction fragment length polymorphism ; RT, reverse transcriptase. 1 To whom correspondence should be addressed (e-mail sprouty!cpcus.jnj.com).
The nucleotide sequence reported in this paper has been submitted to the GenBank database with accession number AF097514.
multiple nucleotide insertions and deletions, as well as in-frame stop codons. Reverse transcriptase-PCR analysis performed with primers specific to the intron-less locus failed to produce a PCR product from brain, liver and skin RNA, indicating that the locus on chromosome 17 is most likely a transcriptionally inactive, fully processed pseudogene. These results suggest strongly that there is one structural SCD gene in the human genome, and that it generates two transcripts by use of alternative polyadenyation sites. Although the primary sequence and intronexon structure of SCD is phylogenetically conserved, divergence between rodent and human is seen in the number of SCD genes and in the generation of alternative transcripts, suggesting a species-specific component of SCD regulation and function.
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frame encoding a 41.4 kDa protein [29] . The mRNA contains an unusually long 3h-untranslated region of 3.5 kb. Two Scd cDNAs, Scd-1 and Scd-2, were isolated subsequently from mouse 3T3-L1 adipocytes [30, 31] . Like rat Scd, mouse Scd-1 and Scd-2, encoded by different genes, have identical transcript sizes of 4.9 kb and contain 3.5 and 3.6 kb 3h-untranslated regions respectively. Under normal conditions, mouse SCD-1 is expressed in adipose tissue whereas SCD-2 is expressed principally in the brain [31] .
The genomic structures for all three genes are very similar, spanning approx. 15 kb and consisting of six exons and five introns [30] [31] [32] . To date, several other Scd cDNAs have been isolated from different species, including carp [14] , hamster [33] , sheep [34] and yeast [35] . Although differences in the molecular masses of these proteins have been reported, all share three regions containing highly conserved histidine motifs [36] . Sitedirected mutagenesis revealed that the conserved histidine motifs are essential for the catalytic activity [36] . The postulated role for these histidine residues is to act as ligands for the iron atom that supports the electron-transfer reaction and thus the oxidationreduction reaction for insertion of the double bond into fatty acids [36] . Despite the importance of lipid metabolism, particularly that of unsaturated fatty acids, in homoeostasis of many organ systems, no studies have examined the structure and regulation of human Scd mRNA expression. Furthermore, the genomic organization of the human SCD gene has not been determined. Previous studies have resulted in the isolation of a 1.5 kb cDNA fragment from human liver, which was reported in the Genbank database (GenBank accession number, Y13647 ; no corresponding publication). Li and co-workers reported the isolation of a 0.76 kb partial cDNA from human adipose tissue by PCR analysis using primers derived from the rat cDNA sequence [28] . RNase protection assay indicated that increased Scd mRNA levels were associated with tumours derived from oesophagus, colon and liver [28] .
Here we report the cloning and full-length sequencing of the primary transcript of human SCD. Our data show, for the first time, that human SCD is expressed as two mRNA species (3.9 and 5.2 kb), which are generated by alternative usage of two polyadenylation signals. We describe the mapping of two SCD loci, localized to chromosomes 10 and 17, and the discovery that the SCD locus on chromosome 17 is a fully processed, transcriptionally inactive pseudogene. We report for the first time the genomic structure of the human SCD gene on chromosome 10, which spans 24 kb and is composed of six exons and five introns with an intron-exon organization highly conserved with rat and mouse SCD genes. Significantly, both gene number and transcriptional regulation differ markedly between rodent and human, suggesting a species-specific component of regulation and function of unsaturated fatty acid metabolism.
EXPERIMENTAL

Screening of the keratinocyte cDNA library
A human-foreskin keratinocyte cDNA library (Clontech, La Jolla, CA, U.S.A.) was screened using a partial PCR-generated Scd cDNA from human surgical scalp biopsies that was subcloned into pBlueScript (Stratagene, La Jolla, CA, U.S.A.). The probe was labelled with [α-$#P]dCTP using a random-primer labelling kit from Amersham Pharmacia (Arlington Heights, IL, U.S.A.) according to supplier's instructions. Plaque lift filters were hybridized overnight in hybridization buffer containing 6iSSC [where 1iSSC is 0.15 M NaCl\0.015 M sodium citrate (pH 7.0)], 5iDenhardt's, 50 % formamide, 0.5 % SDS, 0.1 mg\ml sonicated salmon sperm, at 42 mC. The filters were washed twice at room temperature for 20 min in 2iSSC\0.1 % SDS buffer, and twice in 1iSSC\0.1 % SDS buffer at 65 mC for 1 h.
3h-RNA end-region determination by 3h-RACE (rapid amplification of cDNA ends)
The 3h-untranslated sequence was obtained by 3h-RACE reaction using a Marathon cDNA amplification kit with Advantage KlenTaq Polymerase Mix according to the manufacturer's instructions (Clontech). In essence, the first cDNA strand was synthesized from poly(A) + RNA of human brain and liver (Clontech), adipose (InVitrogen, Carlsbad, CA, U.S.A.) and human ' scalp hair-plugs ' (discarded material from hair-follicletransplant surgery) employing a 3h-RACE general adaptor primer 1 (AP1) supplied by the manufacturer (Clontech). The 3h-RACE gene-specific primer was 5h-GCTGATCCTCATAATTCCCGA-CGTGGC-3h (nucleotides 737-763, see Figure 2 , below). The PCR amplification was performed under stringent conditions including : (i) denaturing at 94 mC for 1 min ; (ii) five cycles of 94 mC for 30 s and 72 mC for 4 min ; (iii) five cycles of 94 mC for 30 s and 70 mC for 4 min ; and (iv) 25 cycles of 94 mC for 30 s and 68 mC for 4 min in a total volume of 50 µl. After the cycling was completed, the PCR products were analysed on a 1 % agarose gel. The PCR products were subcloned in TA vector pCR2.1 (InVitrogen), and the nucleotide sequences of the cDNA clones were determined.
RNA isolation and Northern-blot analysis
Total RNA was isolated from human scalp hair-plugs using the RNA STAT-60 (Tel-Test ' B ', Friendswood, TX, U.S.A.). The total RNA was resolved by electrophoresis on a 6 % (w\v) formaldehyde\1.0 % (w\v) agarose gel, and transferred on to nylon filters (Hybond-N, Amersham Pharmacia). Hybridization with $#P-labelled probes was carried out at 68 mC in ExpressHyb hybridization solution (Clontech) plus 0.1 % µg\ml salmon sperm DNA for 1 h. Stringent washes were performed in 2iSSC\1.0 % SDS at 65 mC for 1 h and blots exposed to BioMax-MR films with an intensifying screen at k80 mC. Hybridization of the Northern blots of poly(A) + RNA from various human tissues (MTN blot, Clontech) was performed according to the procedure recommended by the manufacturer.
Southern-blot analysis
Human genomic DNA (10 µg\lane ; Clontech) was digested with individual restriction enzymes as indicated, electrophoresed on a 0.8 % agarose gel, and then transferred on to a nylon membrane (Hybond-N). The membrane was hybridized for 1 h at 68 mC in ExpressHyb hybridization solution and 0.1 % µg\ml salmon sperm DNA and then washed with 0.1iSSC\0.1 % SDS at 65 mC for 1 h.
Genomic-library screening
Human genomic-DNA library derived from whole-blood DNA in λ DASH vector (Stratagene) and chromosome-specific libraries LA10NS01 (chromosome 10, EcoRI), LA17NS03 (chromosome 17, EcoR1), LL10NS01 (chromosome 17, HindIII), and LL17NS02 (chromosome 17, HindIII ; American Type Culture Collection, Rockville, MD, U.S.A.) were screened with $#P-labelled probes containing the entire Scd cDNA transcript. Hybridization, washing and autoradiography were performed as described above for Southern-blotting analysis.
Chromosome mapping of the SCD gene
A panel of mono-chromosomal somatic-cell hybrid clones was used for the assignment of the human SCD gene locus (Quantum Biotechnologies Inc., Montreal, Canada). The blot was prepared with the EcoRI restriction enzyme. Conditions for the hybridization and washing were the same as for the Southern blotting. Hybridization signals were detected by exposure to X-ray film at k80 mC for 4 days.
Reverse transcriptase (RT)-PCR analyses
Total RNA (5 µg) isolated from human scalp hair-plug or 5 µg of total RNA from human brain or liver (Clontech) were reverse transcribed in a random-primed reaction with an RT-PCR kit (Stratagene). The Scd primers used were as follows : a 5h primer (sense, position 263-283) and a 3h primer (antisense, position 526-545). The pseudo-SCD gene primers used were : a 5h primer (sense, position 1605-1625) and a 3h primer (antisense, position 1801-1821). PCR amplifications were carried out for 25 cycles, each cycle consisting of 30 s at 94 mC, 30 s at 55 mC and 40 s at 72 mC for both primer pairs. The PCR products were separated by electrophoresis on a 1.3 % agarose gel and visualized by ethidium bromide staining. The expected sizes of the PCR fragments were 283 bp for Scd and 217 bp for pesudo-SCD gene.
DNA sequencing
The DNA sequences in both directions were determined by the dideoxy chain-termination method using Sequenase version 2.0 (U.S Biochemical Corp., Cleveland, OH, U.S. 
RESULTS
Cloning of a skin cDNA encoding Scd from a human-foreskin keratinocyte cDNA library
To generate a probe for screening the keratinocyte library, we first amplified a 580 bp PCR product from human scalp hairplug total RNA using primers derived from human adipose Scd (forward, nucleotides 20-40 ; reverse, nucleotides 621-641 [28] ). The amplified fragment was subcloned and its identity was confirmed by nucleotide-sequence analysis. By screening approx. 1i10' plaques, a total of eight overlapping clones were isolated, subcloned and subjected to DNA sequencing. Sequence analysis revealed that all of the clones were partial clones. Figure 2 ). Neither a conserved polyadenylation signal nor a poly(A) + tail were found in the 3h-untranslated region, suggesting that the cDNA sequence was incomplete.
Use of 3h-RACE to isolate the full-length human Scd transcript(s)
To obtain full-length cDNA for human SCD, we applied 3h-RACE to poly(A) + RNA isolated from human scalp hair-plugs, adipose tissue, brain and liver using a Marathon cDNA Amplification Kit. The sense primer was designed from the sequence of λ clone 21 (position 737-763 bp in Figure 2 ). 3h-RACE was carried out by Advantage cDNA Polymerase Mix, which possesses 3h-5h exonuclease activity to ensure that DNA fidelity is maintained during the amplification process. Two amplification products of $ 3.2 and $ 4.4 kb were amplified specifically from both liver and brain (Figure 1 ), suggesting the presence of multiple poly(A) + tails. A 2.5 kb PCR product was amplified from both skin and adipose mRNAs ( Figure 1 ). All PCR products from liver, brain, adipose and skin were subcloned, and completely sequenced in both directions.
The cDNA sequences from all PCR fragments amplified from four different tissues and the λ clones isolated from the human keratinocyte λ cDNA library were all identical in the areas of overlap. We also performed 5h-RACE on liver, brain, adipose and skin mRNA using the general adaptor primer 1 (AP1) and an antisense primer, which complemented the 3h-RACE genespecific primer. Sequencing analysis revealed that all of the cloned sequences are identical to each other and to λ clone 34 (see Figure 1 ). These data indicate that there is one open reading frame for human Scd mRNA transcripts from all four tissues examined under the conditions used (see the Experimental section). The complete nucleotide cDNA of human Scd is depicted in Figure 2 . It is composed of 5221 bp : 235 bp in the 5h-untranslated sequence, 1080 bp in the open reading frame encoding 359 amino acids, and 3906 bp in the 3h-untranslated region containing two consensus polyadenylation signals (AATAAA) and a poly(A) + tail 14 bp downstream of the most 3h polyadenylation signal. The size of the cDNA sequence corresponded well with that of the 3.2 kb PCR fragment amplified from liver or brain if the internal polyadenylation signal was used. Sequence of the 3.2 kb fragment from both liver and brain revealed that it did contain a poly(A) + tail, which began 18 bp
Figure 2 The cDNA and deduced amino acid sequences of human Scd
The numbering of nucleotides is shown on the left. Amino acids are given by their single-letter code, and are numbered on the right. Sequence used to design the primer for 3h-RACE is underlined. The three histidine-containing motifs are double underlined. Polyadenylation signals are boxed (AATAAA). Possible RNA destabilization sequences are dash boxed (ATTTA). This sequence has been submitted to the GenBank database with accession no. AF097514.
downstream from the internal polyadenylation signal ; this suggests that the 3.2 kb transcript originated from alternative poly(A) + signal usage. The 2.5 kb PCR fragment amplified from skin and adipose tissue did not possess a poly(A) + tract or a polyadenylation signal at its 3h terminus despite its isolation from oligo-dT primed cDNA. This suggests that the 2.5 kb fragments resulted from non-poly(A) + tail priming of mRNA. To generate a complete 3h-untranslated sequence from skin mRNA, a nested primer was synthesized from the 3h end of the 2.5 kb PCR fragment (nucleotides 2521-2538 in Figure 2 ) and was used for a second round of 3h-RACE on skin mRNA. A 2.7 kb PCR fragment was amplified (Figure 1) , and sequence analysis indicated that it had a sequence identical with the remainder of the human Scd cDNA sequences. A 1.5 kb cDNA fragment was isolated previously from human liver and reported in the GenBank database. It contains the entire coding region of Scd plus an upstream region of 208 bp and a downstream 3h-untranslated region of 157 bp ending with 26 bp of As. However, no classic polyadenylation signals were found in the 3h-untranslated region, indicating an incomplete cDNA sequence. The sequence of liver cDNA reported in the database differs from the sequence reported here at a number of locations : eight nucleotides in the coding region (resulting in six variant amino acids in the liver Scd cDNA : Ser-25 Pro, Arg-26 Gly, Leu-224 Met, Thr-320 Asn, Cys-326 Trp and Ala-333 Thr) ; three positions in the 5h-untranslated region ; and 17 positions in the 3h-untranslated region. At no time were we able to isolate a clone representing the liver cDNA deposited previously in the database. We also compared the partial adipose Scd cDNA sequence (which differs from the liver cDNA sequence) with our Scd cDNA sequence. Differences (15 bp) were found in the areas of overlap resulting in a total of six amino acid changes in the adipose Scd cDNA, which include : Leu-5 Met, Asp-8 Glu, Ser-25 Pro, Arg-26 Gly, Leu-224 Met and Phe-237 Cys.
A GenBank database search using Blast [37] revealed that our Scd cDNA sequence was highly homologous with those of mouse Scd-1 and Scd-2. The nucleotide and deduced amino acid sequences of human Scd were compared with those of mouse Scds. Within the open reading frame, the nucleotide identity between the human Scd sequence and mouse Scd-1 and Scd-2 were 85 and 82 %, respectively. Two of the histidine-containing regions (amino acids 120-126 and 157-171, Figure 2 ) of human Scd were 100 % identical with those of Scd-1 and Scd-2. The third histidine-containing region (amino acids 294-308, Figure 2 ) was 87 % identical to both Scd-1 and Scd-2, suggesting the importance of those regions. Furthermore, the spacing of these histidine regions is conserved between human and mouse Scds. The 5h-untranslated region of human Scd was also highly homologous to mouse Scd-1 and Scd-2, showing 70 and 81 % nucleotide identities, respectively. In addition, like mouse Scd-1 and Scd-2, human Scd has a long 3h-untranslated region ; this region shows a relatively low sequence identity with that of mouse Scd-1 (68 %) and Scd-2 (68 %).
Northern-blot analysis and characterization of the 3h-untranslated region of the Scd transcripts
To confirm the size of full-length transcript(s) obtained with 3h-RACE and to determine the pattern of human Scd expression, Northern-blot analysis of poly(A) + mRNA from multiple human tissues (MTN blot) and total RNA from human scalp hair-plugs was performed. Hybridization with probe A (clone 21, Figure 1 ; nucleotides 283-2005, Figure 2 ) and probe B (located at the most 3h end of the Scd cDNA sequence, Figure 1 ; nucleotides 4390-5190, Figure 2 ) indicated that the two Scd transcripts of 3.9 and 5.2 kb arise from differential usage of two distinct polyadenylation signals that are separated by 1.2 kb in all the tissues examined ( Figure 3) . Indeed, probe A, which is located 5h to the proximal polyadenylation signal, hybridized with both the 3.9 and the 5.2 kb transcripts ( Figure 3A ) whereas probe B, located 3h to the internal polyadenylation signal, hybridized only with the 5.2 kb species ( Figure 3B ). There were other hybridization bands observed in liver tissue with probe B (Figure 3B, lane 5) . Equal loading of mRNAs in the multiple-tissue blot was confirmed by re-probing for human β-actin ( Figure 3A , lower panel). Scd appeared to be expressed ubiquitously, suggesting a fundamental role for the protein. However, the overall level of Scd transcripts differed among tissues, with high levels in brain and liver ( Figure 3A, lanes 2 and 5, respectively) , intermediate levels in heart and lung ( Figure 3A, lanes 1 and 4, respectively) and low levels in placenta, skeletal muscle, kidney and pancreas ( Figure 3A, lanes 3, 6, 7 and 8, respectively) . The skin sample ( Figure 3A , lane 9) cannot be compared directly here for overall level of Scd transcripts since it represents total RNA ; although, on multiple-tissue blots of total RNA, skin was found to express intermediate levels of Scd transcripts (results not shown). It must be noted, in addition, that the relative concentrations of the two transcripts differed among tissues, with the 5.2 kb transcript being most abundant in brain and the 3.9 kb transcript more abundantly expressed in heart and skin.
Genomic analysis of the human SCD gene
Multiple genes encoding Scds have been isolated and characterized in the mouse and rat genomes [30] [31] [32] . As a first step in elucidating the human genomic structure of the SCD gene(s) in the human genome, we performed a Southern-blot analysis of genomic DNA digested by BglII, EcoRI, EcoRV, HindIII and PstI and hybridized sequentially with three $#P-labelled probes ; p1, p2 and p3 derived from human Scd cDNA (Figure 4 , left, middle and right panels, respectively). Probe p1, a 283 bp fragment, corresponds to nucleotides 263-545 ; p2, a 206 bp fragment, corresponds to nucleotides 677-882, and probe p3 is a 801 bp fragment representing the most 3h end of the Scd cDNA sequence (nucleotides 4390-5190) and harbouring an EcoRI restriction-enzyme site at bp 4847 (the locations of the probes are depicted in Figure 8B , see below). All three probes yielded two hybridization bands in all restriction-endonuclease digests with the exception of probe p3 hybridizing to three bands in the EcoRI enzyme digest (Figure 4, right panel, EcoRI) . This difference is due to the presence of an EcoRI site in the Scd cDNA sequence and thus accounts for two fragments of 2.5 and 4.0 kb generated by EcoRI digestion. These results indicated that there are two SCD loci in the human genome and suggested
Figure 5 Chromosome mapping of SCD loci
Southern-blot analysis performed on DNA derived from somatic-cell hybrids containing individual human chromosomes is depicted in lanes 1-22, X and Y in a mouse or hamster background using probes p1 (upper panel) and p3 (lower panel). Probes p1 and p3 were the same as in Figure 4 . Genomic DNAs from human, mouse and hamster are also indicated ; mix indicates a mixture of mouse and human genomic DNA. DNA size markers (in kb) are indicated on the left.
that the three bands detected by p3 in EcoRI digest highlight an EcoRI restriction fragment length polymorphism (RFLP) in one of the loci.
Chromosome mapping of SCD genes using a chromosome-specific Southern blot
We next attempted to determine the chromosomal location of human SCD loci using EcoRI-digested DNA from a humanrodent mono-chromosomal cell hybrid panel with probes p1 and p3 ( Figure 5 ). The 5.6 kb band identified from total human genomic DNA with p1 ( Figure 
Genomic characterization of the SCD loci on chromosomes 10 and 17
To characterize the genomic structures of the two SCD loci localized on chromosomes 10 and 17, we first used PCR to amplify the introns from genomic DNA of human-rodent somatic cell hybrids containing chromosomes 10 and 17 with human-specific primers derived from various regions of the cDNA sequence. To our surprise, reactions performed on chromosome 17 genomic DNA with different cDNA primers consistently yielded one PCR product migrating at the predicted mobility of the cDNA. These results suggested that the SCD locus on chromosome 17 contained no intervening sequences (results not shown). In contrast, PCR fragments ranging in size from 0.7 to 4.0 kb were amplified from chromosome 10 genomic DNA with appropriate primers, suggesting that the SCD locus on chromosome 10 contains introns (results not shown). To further characterize the SCD gene locus on chromosome 17, we screened two endonuclease-digested chromosome 17-specific phage libraries (EcoRI and HindIII) with $#P-labelled cDNA probes consisting of the entire Scd transcript. A total of 10 independent clones were isolated from the HindIII-digested library and no positive clones were isolated from the EcoRI-digested library. Based on PCR analysis with different regions of cDNA and restriction-enzyme mapping, we divided the 10 independent clones into two groups, each consisting of five identical clones. One clone from each group, clone 4 and clone 14, were selected for complete DNA sequencing analysis. Clone 4, which was 3.0 kb in length, contained an uninterrupted linear sequence similar to human Scd cDNA consisting of a 1437 bp 5h-untranslated region, a recognizable complete coding region and a 525 bp 3h-untranslated region. The overlapping areas of nucleotide sequence of clone 4 were compared with human Scd cDNA sequence : the comparison of nucleotides 1203-2521 of clone 4 and nucleotides 1-1317 of Scd cDNA is shown in Figure 6 . As compared with Scd cDNA, clone 4 contained multiple genetic lesions, including substitution, deletion and insertion sites that resulted in two premature in-frame stop codons. The nucleotide identity was 96 % between clone 4 and Scd cDNA sequence in the overlapping region. Clone 14, 5.6 kb in length, is distinguished from clone 4 by a HindIII restriction-enzyme site (nucleotides Molecular characterization of human stearoyl-CoA desaturase 
Figure 7 RT-PCR using total RNA isolated from human tissues with Scdand ψSCD-specific primers
Following incubation with (j) or without (k) RT, cDNA was amplified by PCR using primers specific to either Scd (A) or ψSCD (B). Each PCR reaction (20 µl) was loaded on a 1.2 % agarose gel, electrophoresed and stained with ethidum bromide. B, brain ; L, liver ; S, human scalp hair-plug. In addition to the RT-PCR reactions, positive-control PCR reactions with Scdand ψSCD-specific primers were carried out on 0.01 µg of Scd cDNA (A) and 0.01 µg of ψSCD (B) respectively. M, DNA markers (100 bp ladders), indicated on the right. Figure 2 ) and contained an uninterrupted linear sequence that shared 95 % nucleotide-sequence identity with the human Scd cDNA sequence from bp 1834 to 5219 (results not shown). Furthermore, these results suggest that clones 4 and 14 represent a processed pseudogene for human SCD (ψSCD) and that the structural human SCD genomic locus is localized on chromosome 10.
1834-1839,
RT-PCR using ψSCD-and Scd-specific primers
In order to determine whether ψSCD is transcriptionally active, RT-PCR was performed on human brain, liver and skin RNAs. PCR primers were designed to specifically amplify either ψSCD or Scd. The nucleotide sequences of the primers and the points of divergence are shown in Figure 6 . Figure 7 shows a representative result of an RT-PCR reaction using these primers and RNAs from brain, liver and skin. The expected 283 bp PCR fragment was amplified from human brain, liver, and skin RNAs using Scd-specific primers ( Figure 7A ). No amplification products were visualized in the RT-PCR reaction containing the primers specific for ψSCD ( Figure 7B ). To demonstrate whether the primers were able to amplify a correct-size band under the conditions used, we performed PCR using 0.01 µg of Scd cDNA ( Figure 7A , SCD) or ψSCD DNA ( Figure 7B, ψSCD) . Negative controls were incubated without RT to discount the possibility of genomic DNA contamination. No amplification products were found. The results suggest that ψSCD either is transcriptionally inactive or produces a highly unrelated transcript.
Structural organization of the human SCD gene
Having established that the locus on chromosome 17 was a processed pseudogene, we next set out to determine the genomic structure of the functional SCD gene on chromosome 10. We first screened two endonuclease-digested chromosome 10-specific phage libraries (EcoRI and HindIII) with the same probes used for the chromosome 17-specific library. Three identical λ clones, clones 19, 20 and 21, were isolated from the EcoRI-digested chromosome 10-specific phage library. Clone 19 was selected for detailed analysis by restriction-endonuclease mapping, Southernblotting and nucleotide sequencing. One clone, clone 4, was isolated from a HindIII-digested library. Clone 19, which is 5.9 kb in length, contains approx. 20 % of the 5h-coding region of SCD, including approx. 3.7 kb of 5h-untranslated region\ promoter region and 2.2 kb of nucleotide sequence extending in the 3h direction (Figure 8 ). Clone 4, 5.9 kb in length, contained the central region of the SCD open reading frame. To identify the remaining SCD coding sequence, we screened a human genomic library with the same probes used for the chromosome-specific libraries. A total of 10 independent λ genomic clones were isolated and characterized. Restrictionenzyme mapping revealed that none of the clones represented the ψSCD gene. The genomic clones overlapped with clone 19, clone 4 and with each other to cover the rest of coding region of the SCD locus. Clones 1C, 13 and 3A, which contained inserts of 11, 11.5 and 7.7 kb in size respectively, were chosen for detailed analysis ( Figure 8A ). The total genomic DNA sequence contained within these clones was approx. 24 kb and the restriction-enzyme maps of EcoRI and HindIII is shown in Figure 8(B) . The localization of exon-intron boundaries and the size of the introns were determined either by DNA sequencing or estimated by agarose-gel electrophoresis of PCR-generated DNA fragments using primers complementary to the flanking exons and the genomic λ clone as templates. The organization of the human SCD gene is very similar to that reported for the mouse SCD-1 and SCD-2 and the rat SCD [30] [31] [32] consisting of six exons and five introns. The sequence of the exons in the gene was identical to that obtained for the cDNA, indicating that the genomic clones encoded the human SCD. Table 1 shows the sizes of introns and the intron-exon splicejunction sequences in the coding region of the SCD gene. As shown, exon sizes range from 131 (3rd exon) to 4106 bp (6th exon) and they are interrupted by five introns varying in size from 0.7 to 4.0 kb. The exon-intron boundaries conform to typical splice-donor and acceptor-consensus sequences [38] . Each splice-donor site begins with an invariant GT dinucleotide, 
DISCUSSION
There is a growing list of genes reported to encode Scd in different species such as carp [14] , mouse [30, 31] , rat [32] , sheep [34] and yeast [35] . However, little information is available concerning human Scd with respect to tissue expression, transcript regulation and genomic structure. This report is the first to document the isolation of the full-length Scd cDNA and to characterize the SCD gene. The cDNA sequence reported here represents a full-length transcript because (i) Northern-blot analysis using a probe from a common region of the cDNAs recognized two mRNAs of about 3.9 and 5.2 kb, the sizes of which correlate well with the cDNA clones, (ii) two different polyadenylation sites were found in the Scd cDNA sequence corresponding well to the sizes of these two transcripts, and (iii) a 15 bp poly(A) + tail was identified at the 3h terminus of the cDNA. We have also demonstrated that the 3.9 and 5.2 kb Scd transcripts arise as a consequence of the two different polyadenylation signals, indicating that the two differentially expressed transcripts encode the same 41.5 kDa polypeptide. The function of alternative polyadenylation sites in the 3h-untranslated region is not clear ; however, since SCD responds to many stimuli including nutrient intake, hormones and temperature, this dynamic response may require additional transcriptional control, such as alternative polyadenylation usage. The alternative transcripts may differ in stability or translatability, thus allowing rapid and efficient response to changes in cellular environment [39] . Indeed three AUUUA sequences were found within the 3h-untranslated region, including one in the 3.9 kb transcript and two in the 5.2 kb transcript. This sequence has been identified as the ' mRNA instability ' signal that is involved in mRNA decay [40, 41] . Alternative poly(A) + signal usage and tissue-specific distribution of mRNA isoforms is a regulatory mechanism utilized by the cationic amino acid transporter [42] and eIF-2α genes [43] , both of which require rapid response to cell growth. Similarly, Scd transcripts may increase transiently in rapidly growing cells in order to maintain fluidity of expanding cellular membranes. Indeed, hepatic Scd mRNA increases when clofibrate is administered to mice, a treatment that causes rapid proliferation of organelles and plasma membrane [16] . Considering the fact that the ratio of 3.9 and 5.2 kb Scd transcripts varies dramatically in different human tissues, we speculate that alternative usage of two different polyadenylation sites in Scd could be a mechanism for regulating Scd activity in different tissues. In contrast, the rat Scd, mouse Scd-1 and mouse Scd-2 cDNAs all have a single functional polyadenylation signal sequence (AATAAA), approx. 24-30 nucleotides from the poly(A) + track [30] [31] [32] . It would appear that the first polyadenylation signal found in the human primary transcript is absent in the rat and mouse. This difference may be related to the fact that the mouse has at least two structural SCD genes whereas humans only have one structural SCD gene. Thus despite conservation of a long 3h-untranslated region in human and rodent, different mechanisms of transcriptional regulation have evolved. The species-specific number of SCD genes and differences in transcriptional regulation suggest that rodent and human may utilize oleic acid in functions that are unique to each species. In support of this, Scd mRNA, as detected by in situ hybridization, is expressed in overlapping as well as unique patterns in rodent and human skin (results not shown), an organ that shows several species-specific adaptations. Relevant to lipid metabolism is the species-specific composition of sebum, the secretory product that covers the surface of the skin [44] . Indeed, it is the sebum-secreting sebaceous gland that shows differential expression of Scd mRNA in rodent and human (results not shown).
Because the sequences reported here diverge from the sequences reported earlier for human liver and adipose tissues, it is important to address the possibility that multiple Scd isoforms are encoded by multiple genes. We found that all PCR fragments amplified from 3h-RACE analysis in four different human tissues or the original λ cDNA clones isolated from human-foreskin keratinocyte cDNA library yielded consistently one single open reading frame. Under no conditions were we able to detect sequences with the magnitude of changes seen in the previously identified liver or adipose sequences. We thus conclude that the sequence reported in Figure 2 is the major product of the SCD gene. Further support for this conclusion was provided by Northern-blot analysis. Because no detectable hybridization bands other than the 3.9 and 5.2 kb transcripts were observed with probes covering almost the entire Scd transcript, this implied that there could not be alternative spliced isoforms in the human tissues examined.
To further test the possibility of multiple SCD genes, we undertook genomic analysis. Southern blotting of human genomic DNA digested with different restriction endonucleases demonstrated clearly the presence of only two loci in the human genome (Figure 4 ). This conclusion was further substantiated by chromosome mapping of a mono-chromosomal somatic-cellhybrid Southern blot that mapped the two loci to chromosomes 10 and 17 ( Figure 5 ). During the course of elucidating the genomic structures of each locus, we discovered that the SCD locus on chromosome 17 is a processed pseudogene ( Figure 6 ). The pseudogene sequence, in comparison with the corresponding mRNA, appeared to accumulate 30 random point mutations and three nucleotide insertions in the coding region, including a C T and a C A mutation at bp 1815 and 1817, which creates a predicted in-frame stop codon in the middle of the first histidine cluster motif. In addition, primers that amplify selectively the pseudogene failed to produce a PCR product in any tissue tested in the RT-PCR experiments, indicating that this gene appears to be transcriptionally inactive (Figure 7 ). Although we cannot rule out transcription of the SCD pseudogene in any other tissues, we can predict that if a protein is encoded from such a transcript, it would be significantly truncated, containing none of the histidineconsensus motifs and, in all probability, therefore functionally inactive. These results, taken together, led us to conclude that there is only one structural SCD gene and that it is on chromosome 10. The localization of the structural SCD gene on human chromosome 10 was further confirmed by the isolation of several individual genomic clones from the two chromosome 10-specific libraries. In addition, the two mouse genes SCD-1 and SCD-2 co-localize to chromosome 19 [45] , which has a syntenic region on human chromosome 10. In light of our results, we believe that the disparate sequences reported for human Scd between laboratories are not due to the presence of different isoforms generated by alternative splicing or by different genes.
As a first step towards studying the mechanism of SCD gene regulation, we have analysed the genomic organization of the gene which encodes the human Scd protein. To our knowledge, this is the first report describing the organization of the human SCD gene. The gene spanning 24 kb is organized into six exons and five introns, with coding sequence distributed in all of the exons. As expected, differences were found in length among the introns in the genes of human and mouse. The human SCD exon structure, in terms of size, looks surprisingly similar to that of mouse SCD-1 and SCD-2 and rat SCD. Particularly, the intron-exon boundaries in the human gene correspond exactly to the locations of those in the mouse SCD-1. Although the functional significance of this conservation is unknown, it may reflect conserved protein-domain organization, since exon structure may, in many cases, represent functional domains of proteins [38] . Previous primary structure analysis of seven desaturase sequences isolated from different species predicted that all would generate hydrophobic proteins each containing two transmembrane domains and three histidine-containing regions localized to the cytoplasmic face of the endoplasmic reticulum [36] . The conserved histidine-containing regions have a consistent distance with respect to these membrane-spanning domains in all the sequences compared [36] . Comparison of the genomic structure with the proposed protein structural domains of human SCD reveal an absolute correlation between the regions encoding the three histidine-containing regions (exons 3, 4 and 6, respectively ; Figure 8 ). The locations of the intron-exon boundaries in the corresponding part of the gene suggest a close relationship between exon boundaries and protein domains. Further work will be required on this aspect of the SCD gene and on its relevance for regulating the structural and catalytic properties of the enzyme.
In summary, we have isolated and characterized the human SCD gene and shown conclusively that a single gene encodes the two Scd transcripts. Genomic mapping localized this gene to human chromosome 10. In addition, we have identified a fully processed pseudo-SCD gene localized to chromosome 17 that is transcriptionally inactive. The successful cloning of the fulllength cDNA encoding human Scd will allow for a more comprehensive investigation of the transcriptional regulation of SCD than was possible previously. Moreover, the present studies provide a molecular framework for future studies on the mechanism involved in the regulation of this gene and will allow investigation into the role of oleic acid in conserved as well as species-specific lipid metabolism.
